$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti

$rmti Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000162828023038781 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q4
Revenue	$22.09M	$23.77M	$19.31M
YoY Change	14.39%	27.18%	25.97%
Cost Of Revenue	$19.22M	$21.57M	$16.97M
YoY Change	13.26%	20.4%	-3.36%
Gross Profit	$2.870M	$2.202M	$2.340M
YoY Change	22.65%	183.4%	-204.89%
Gross Profit Margin	12.99%	9.26%	12.12%
Selling, General & Admin	$3.249M	$3.445M	$4.150M
YoY Change	-21.71%	-14.22%	-12.41%
% of Gross Profit	113.21%	156.45%	177.35%
Research & Development	$168.0K	$494.0K	$156.0K
YoY Change	7.69%	5.33%	-88.78%
% of Gross Profit	5.85%	22.43%	6.67%
Depreciation & Amortization	$550.0K	$400.0K	$156.0K
YoY Change	252.56%	300.0%	17.29%
% of Gross Profit	19.16%	18.17%	6.67%
Operating Expenses	$3.417M	$3.939M	$4.306M
YoY Change	-20.65%	-12.17%	-29.73%
Operating Profit	-$547.0K	-$1.737M	-$1.966M
YoY Change	-72.18%	-53.16%	-76.48%
Interest Expense	-$965.0K	$411.0K	-$394.0K
YoY Change	144.92%	-13.66%	-32.3%
% of Operating Profit
Other Income/Expense, Net		-$135.0K
YoY Change		-71.99%
Pretax Income	-$1.512M	-$1.872M	-$2.360M
YoY Change	-35.93%	-55.32%	-73.6%
Income Tax
% Of Pretax Income
Net Earnings	-$1.512M	-$1.872M	-$2.360M
YoY Change	-35.93%	-55.32%	-73.6%
Net Earnings / Revenue	-6.84%	-7.88%	-12.22%
Basic Earnings Per Share		-$0.07
Diluted Earnings Per Share	-$0.05	-$0.07	-$0.20
COMMON SHARES
Basic Shares Outstanding	28.49M shares	28.49M shares	11.63M shares
Diluted Shares Outstanding		27.52M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.94M	$11.73M	$21.49M
YoY Change	-49.12%	-57.44%	-4.22%
Cash & Equivalents	$8.983M	$7.759M	$10.10M
Short-Term Investments	$1.952M	$3.971M	$11.39M
Other Short-Term Assets	$1.063M	$1.596M	$1.745M
YoY Change	-39.08%	-33.69%	-39.01%
Inventory	$5.871M	$5.486M	$5.814M
Prepaid Expenses
Receivables	$10.90M	$9.361M	$6.259M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$28.77M	$28.17M	$35.31M
YoY Change	-18.52%	-33.49%	0.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.402M	$6.771M	$2.194M
YoY Change	191.8%	199.07%	-11.75%
Goodwill	$900.0K	$921.0K	$900.0K
YoY Change	0.0%	0.0%	-2.28%
Intangibles	$10.76M	$10.90M	$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets	$527.0K	$527.0K	$523.0K
YoY Change	0.76%	0.96%	-15.51%
Total Long-Term Assets	$23.40M	$24.43M	$11.33M
YoY Change	106.65%	106.57%	-14.76%
TOTAL ASSETS
Total Short-Term Assets	$28.77M	$28.17M	$35.31M
Total Long-Term Assets	$23.40M	$24.43M	$11.33M
Total Assets	$52.17M	$52.61M	$46.64M
YoY Change	11.88%	-2.92%	-3.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.516M	$3.929M	$4.053M
YoY Change	11.42%	28.78%	8.4%
Accrued Expenses	$7.149M	$6.708M	$7.702M
YoY Change	-7.18%	13.95%	51.32%
Deferred Revenue	$46.00K	$46.00K	$1.731M
YoY Change	-97.34%	-97.87%	-20.27%
Short-Term Debt	$244.0K	$488.0K	$503.0K
YoY Change	-51.49%	-51.49%	15.1%
Long-Term Debt Due	$0.00	$5.631M	$1.631M
YoY Change	-100.0%	9.74%	-77.9%
Total Short-Term Liabilities	$16.64M	$21.41M	$17.69M
YoY Change	-5.96%	10.7%	-15.62%
LONG-TERM LIABILITIES
Long-Term Debt	$8.293M	$3.331M	$7.555M
YoY Change	9.77%	-62.83%	-42.7%
Other Long-Term Liabilities	$14.00K	$14.00K	$14.00K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Liabilities	$8.307M	$3.345M	$7.569M
YoY Change	9.75%	-62.73%	-42.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.64M	$21.41M	$17.69M
Total Long-Term Liabilities	$8.307M	$3.345M	$7.569M
Total Liabilities	$30.88M	$31.09M	$32.53M
YoY Change	-5.06%	-18.3%	-29.34%
SHAREHOLDERS EQUITY
Retained Earnings	-$397.2M	-$395.7M	-$388.8M
YoY Change	2.16%	2.4%	5.06%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$21.30M	$21.52M	$14.10M
YoY Change
Total Liabilities & Shareholders Equity	$52.17M	$52.61M	$46.64M
YoY Change	11.88%	-2.92%	-3.99%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q4
OPERATING ACTIVITIES
Net Income	-$1.512M	-$1.872M	-$2.360M
YoY Change	-35.93%	-55.32%	-73.6%
Depreciation, Depletion And Amortization	$550.0K	$400.0K	$156.0K
YoY Change	252.56%	300.0%	17.29%
Cash From Operating Activities	-$43.00K	-$3.749M	-$594.0K
YoY Change	-92.76%	240.2%	-93.42%
INVESTING ACTIVITIES
Capital Expenditures	$43.00K	$12.37M	$81.00K
YoY Change	-46.91%	-10674.36%	-171.05%
Acquisitions
YoY Change
Other Investing Activities	$2.051M	$2.089M	$3.305M
YoY Change	-37.94%	-114.33%	405.35%
Cash From Investing Activities	$2.008M	-$10.29M	$3.214M
YoY Change	-37.52%	-29.96%	495.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-742.0K	12.84M	-5.498M
YoY Change	-86.5%	-741.56%	238.55%
NET CHANGE
Cash From Operating Activities	-43.00K	-3.749M	-594.0K
Cash From Investing Activities	2.008M	-10.29M	3.214M
Cash From Financing Activities	-742.0K	12.84M	-5.498M
Net Change In Cash	1.223M	-1.198M	-2.878M
YoY Change	-142.49%	-93.27%	-71.53%
FREE CASH FLOW
Cash From Operating Activities	-$43.00K	-$3.749M	-$594.0K
Capital Expenditures	$43.00K	$12.37M	$81.00K
Free Cash Flow	-$86.00K	-$16.12M	-$675.0K
YoY Change	-87.26%	1536.65%	-92.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7555000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2600000	usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	15000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	15000	shares
CY2022Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2022Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	1000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	402701000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-388759000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	163000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14106000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	46635000	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	5000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	5631000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1631000	usd
CY2023Q3	us-gaap	Notes Payable NotesPayable	488000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	503000	usd
CY2022Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	66000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17691000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2581000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2088000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	32529000	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	15000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28489663	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12163673	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12163673	shares
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	53497000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	51760000	usd
	us-gaap	Gross Profit GrossProfit	1737000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2963000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1743000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11845000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14814000	usd
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	4000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	411000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	476000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	-10000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1503000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16317000	usd
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.26
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27521088	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18463673	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21526978	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12902890	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12902890	shares
	us-gaap	Net Income Loss NetIncomeLoss	-16317000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	5000	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-90000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1941000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4185000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14106000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-3000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	193000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12542000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-3305000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-18000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	309000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	9528000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1872000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-69000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	13719000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	212000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	21518000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2535000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7162000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	-179000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-4807000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-4967000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14916000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	97000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	20145000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-4190000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	5000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	176000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	16136000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6927000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16317000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	894000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	422000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	714000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	95000	usd
	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	1098000	usd
	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	307000	usd
	rmti	Operating And Finance Lease Right Of Use Asset Amortization Expense OperatingAndFinanceLeaseRightOfUseAssetAmortizationExpense	1529000	usd
	rmti	Operating And Finance Lease Right Of Use Asset Amortization Expense OperatingAndFinanceLeaseRightOfUseAssetAmortizationExpense	1518000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	276000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	276000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-1000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	3000	usd
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	220000	usd
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	4000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3102000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1454000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1561000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	921000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-875000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2058000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-124000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-688000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1113000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1435000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1033000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	756000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-3798000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1427000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9369000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16817000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	3752000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	17389000	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	11301000	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	11972000	usd
	rmti	Payments To Acquire Machinery And Equipment Excluding Cash Paid In Asset Acquisition PaymentsToAcquireMachineryAndEquipmentExcludingCashPaidInAssetAcquisition	241000	usd
	rmti	Payments To Acquire Machinery And Equipment Excluding Cash Paid In Asset Acquisition PaymentsToAcquireMachineryAndEquipmentExcludingCashPaidInAssetAcquisition	197000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	12361000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5053000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5614000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	500000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	6750000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	748000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	941000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	388000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	13763000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15016000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	43000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	106000	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	15000000	usd
	rmti	Payments Of Stock Issuance Costs Preferred Stock PaymentsOfStockIssuanceCostsPreferredStock	0	usd
	rmti	Payments Of Stock Issuance Costs Preferred Stock PaymentsOfStockIssuanceCostsPreferredStock	85000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12084000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22134000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-5000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2343000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-300000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10102000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13280000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7759000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12980000	usd
	us-gaap	Interest Paid Net InterestPaidNet	929000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1261000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-90000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	5000	usd
	us-gaap	Notes Assumed1 NotesAssumed1	733000	usd
	us-gaap	Notes Assumed1 NotesAssumed1	0	usd
	rmti	Asset Acquisition Deferred Consideration AssetAcquisitionDeferredConsideration	5000000	usd
	rmti	Asset Acquisition Deferred Consideration AssetAcquisitionDeferredConsideration	0	usd
	rmti	Area Of Operating Space AreaOfOperatingSpace	175000	sqft
CY2023Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	11700000	usd
CY2023Q3	rmti	Working Capital Net WorkingCapitalNet	6800000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9400000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</span></div>
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.26
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18463673	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18463673	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12902890	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12902890	shares
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1872000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-4190000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6927000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-16317000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16317000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-16317000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27521088	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18463673	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18463673	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21526978	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21526978	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12902890	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.26
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7064698	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20308486	shares
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	rmti	Number Of Distribution And License Agreements NumberOfDistributionAndLicenseAgreements	5	agreement
CY2023Q3	rmti	Distribution And License Agreements Reacquisition Payable Number Of Installments DistributionAndLicenseAgreementsReacquisitionPayableNumberOfInstallments	2	installment
	rmti	Average Payment Term Of Customers AveragePaymentTermOfCustomers	P30D
	rmti	Average Payment Term Of Distributors AveragePaymentTermOfDistributors	P60D
CY2023Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	23771000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	61519000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	18691000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	53497000	usd
CY2023Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	9361000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	6259000	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	533000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4331000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	3898000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	73000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	0	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	3971000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	11315000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	75000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	11390000	usd
	us-gaap	Depreciation Depreciation	400000	usd
CY2022Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y8M12D
CY2023Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M12D
CY2023Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2335000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3351000	usd
CY2023Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	337000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	351000	usd
CY2023Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2814000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2112000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	5486000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	5814000	usd
CY2023Q3	us-gaap	Inventory Noncurrent InventoryNoncurrent	178000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1276000	usd
CY2023Q3	rmti	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	5664000	usd
CY2022Q4	rmti	Inventory Current And Noncurrent InventoryCurrentAndNoncurrent	7090000	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	5500000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	5800000	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	25000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	25000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15160000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9830000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8389000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7636000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6771000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2194000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	400000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	100000	usd
	us-gaap	Depreciation Depreciation	800000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2240000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2568000	usd
CY2023Q3	rmti	Accrued Unvouchered Receipts Current AccruedUnvoucheredReceiptsCurrent	1947000	usd
CY2022Q4	rmti	Accrued Unvouchered Receipts Current AccruedUnvoucheredReceiptsCurrent	585000	usd
CY2023Q3	rmti	Accrued Manufacturing Expense Current AccruedManufacturingExpenseCurrent	732000	usd
CY2022Q4	rmti	Accrued Manufacturing Expense Current AccruedManufacturingExpenseCurrent	0	usd
CY2023Q3	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	202000	usd
CY2022Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	306000	usd
CY2023Q3	rmti	Research And Development Related Liabilities Current ResearchAndDevelopmentRelatedLiabilitiesCurrent	0	usd
CY2022Q4	rmti	Research And Development Related Liabilities Current ResearchAndDevelopmentRelatedLiabilitiesCurrent	43000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1587000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4200000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6708000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7702000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	15000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	15000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	15000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	15000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28489663	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28489663	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12163673	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12163673	shares
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	136000	usd
CY2023Q3	rmti	Cash Flows From Finance Lease Principal Payments CashFlowsFromFinanceLeasePrincipalPayments	130000	usd
CY2022Q3	rmti	Cash Flows From Finance Lease Principal Payments CashFlowsFromFinanceLeasePrincipalPayments	121000	usd
	rmti	Cash Flows From Finance Lease Principal Payments CashFlowsFromFinanceLeasePrincipalPayments	388000	usd
	rmti	Cash Flows From Finance Lease Principal Payments CashFlowsFromFinanceLeasePrincipalPayments	359000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28489663	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11152673	shares
CY2023Q3	rmti	Common Stock And Pre Funded Warrants Shares Outstanding CommonStockAndPreFundedWarrantsSharesOutstanding	28489663	shares
CY2022Q3	rmti	Common Stock And Pre Funded Warrants Shares Outstanding CommonStockAndPreFundedWarrantsSharesOutstanding	18463673	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1367493	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1311691	shares
CY2023Q3	us-gaap	Convertible Preferred Stock Shares Reserved For Future Issuance ConvertiblePreferredStockSharesReservedForFutureIssuance	1363636	shares
CY2022Q3	us-gaap	Convertible Preferred Stock Shares Reserved For Future Issuance ConvertiblePreferredStockSharesReservedForFutureIssuance	1363636	shares
CY2023Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	35554361	shares
CY2022Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	38772159	shares
CY2022Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	212000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	176000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	714000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	94000	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y2M12D
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y2M12D
CY2023Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M12D
CY2018Q4	rmti	Number Of Additional Agreements NumberOfAdditionalAgreements	3	agreement
CY2023Q3	rmti	Operating Lease And Finance Lease Liability OperatingLeaseAndFinanceLeaseLiability	5400000	usd
CY2023Q3	rmti	Operating Lease And Finance Lease Right Of Use Assets Net OperatingLeaseAndFinanceLeaseRightOfUseAssetsNet	5100000	usd
CY2022Q4	rmti	Operating Lease And Finance Lease Liability OperatingLeaseAndFinanceLeaseLiability	6700000	usd
CY2022Q4	rmti	Operating Lease And Finance Lease Right Of Use Assets Net OperatingLeaseAndFinanceLeaseRightOfUseAssetsNet	6400000	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	422000	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	410000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	1281000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	1289000	usd
CY2023Q3	us-gaap	Variable Lease Cost VariableLeaseCost	112000	usd
CY2022Q3	us-gaap	Variable Lease Cost VariableLeaseCost	101000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	336000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	287000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	534000	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	511000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1617000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1576000	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	142000	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	141000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	424000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	424000	usd
CY2023Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	36000	usd
CY2022Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	44000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	113000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	136000	usd
CY2023Q3	rmti	Finance Lease Expense FinanceLeaseExpense	178000	usd
CY2022Q3	rmti	Finance Lease Expense FinanceLeaseExpense	185000	usd
	rmti	Finance Lease Expense FinanceLeaseExpense	537000	usd
	rmti	Finance Lease Expense FinanceLeaseExpense	560000	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4000	usd
CY2022Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	5000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	12000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	14000	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	716000	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	701000	usd
	us-gaap	Lease Cost LeaseCost	2166000	usd
	us-gaap	Lease Cost LeaseCost	2150000	usd
CY2023Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	461000	usd
CY2022Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	427000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1363000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1338000	usd
CY2023Q3	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	37000	usd
CY2022Q3	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	44000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	114000	usd
CY2022Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y8M12D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.065
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.064
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.065
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.064
CY2023Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.064
CY2022Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.064
CY2023Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.064
CY2022Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.064
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	439000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	168000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1511000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	672000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1021000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	676000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	362000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	666000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	131000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	311000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3464000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	2493000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	259000	usd
CY2023Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	271000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	3205000	usd
CY2023Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	2222000	usd

Files In Submission

Name	View Source	Status
0001628280-23-038781-index-headers.html	Edgar Link	pending
0001628280-23-038781-index.html	Edgar Link	pending
0001628280-23-038781.txt	Edgar Link	pending
0001628280-23-038781-xbrl.zip	Edgar Link	pending
exhibit101toq310q.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rmti-20230930.htm	Edgar Link	pending
rmti-20230930.xsd	Edgar Link	pending
rmti-20230930x10qex311.htm	Edgar Link	pending
rmti-20230930x10qex321.htm	Edgar Link	pending
Show.js	Edgar Link	pending
rmti-20230930_cal.xml	Edgar Link	unprocessable
rmti-20230930_def.xml	Edgar Link	unprocessable
rmti-20230930_lab.xml	Edgar Link	unprocessable
rmti-20230930_pre.xml	Edgar Link	unprocessable
rmti-20230930_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti

2023 Q4 Form 10-Q Financial Statement

#000162828023038781 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMTI ROCKWELL MEDICAL, INC. Stock $rmti

2023 Q4 Form 10-Q Financial Statement

#000162828023038781 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti